Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression-Reference-Cited by-同舟云学术

Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression

Published:2021-03-08 Issue:6 Volume:36 Page:1420-1429
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Chohan Harneek¹^ORCID,Senkevich Konstantin²³,Patel Radhika K.¹,Bestwick Jonathan P.¹,Jacobs Benjamin M.¹,Bandres Ciga Sara⁴,Gan‐Or Ziv²³⁵,Noyce Alastair J.¹⁶^ORCID

Affiliation:

1. Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry Queen Mary University of London London UK

2. Department of Neurology and Neurosurgery McGill University Montréal Quebec Canada

3. Montreal Neurological Institute McGill University Montréal Quebec Canada

4. Molecular Genetics Section, Laboratory of Neurogenetics National Institute on Aging, National Institutes of Health Bethesda Maryland USA

5. Department of Human Genetics McGill University Montréal Quebec Canada

6. Department of Clinical and Movement Neurosciences UCL Institute of Neurology London UK

Funder

Canada First Research Excellence Fund

Michael J. Fox Foundation for Parkinson's Research

Fonds de Recherche du Québec - Santé

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28551

Reference66 articles.

1. Insulin resistance and Parkinson’s disease: A new target for disease modification?

2. The Association Between Type 2 Diabetes Mellitus and Parkinson’s Disease

3. The role of mitochondria in insulin resistance and type 2 diabetes mellitus

4. Diabetes and Risk of Parkinson's Disease: A systematic review and meta-analysis

5. Meta‐analysis of early nonmotor features and risk factors for Parkinson disease

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parkinson’s Disease;International Encyclopedia of Public Health;2025

2. Movement disorders related to antidiabetic medications: a real-world pharmacovigilance study;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-12

3. Pesticides and lifestyle factors are associated with disease severity of Parkinson’s disease: a longitudinal study;2024-09-06

4. The association between type 2 diabetes mellitus and Parkinson's disease; a systematic review and meta-analysis;Brain Disorders;2024-09

5. Update: Protective and risk factors for Parkinson disease;Parkinsonism & Related Disorders;2024-08